FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms

Cancer drug resistance is a common, unpredictable phenomenon that develops in many types of tumors, resulting in the poor efficacy of current anticancer therapies. One of the most common, and yet the most complex causes of drug resistance is a mechanism related to dysregulation of tumor cell signali...

Full description

Bibliographic Details
Published in:	Frontiers in Oncology
Main Authors:	Jakub Szymczyk, Martyna Sochacka, Patryk Chudy, Lukasz Opalinski, Jacek Otlewski, Malgorzata Zakrzewska
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Subjects:	cancer FGF1 FGFR1 drug resistance anticancer drugs taltobulin
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1011762/full

Similar Items

FGF1 Protects MCF-7 Cells against Taltobulin through Both the MEKs/ERKs and PI3K/AKT Signaling Pathway
by: Jakub Szymczyk, et al.
Published: (2023-06-01)

Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap
by: Jakub Szymczyk, et al.
Published: (2024-09-01)

FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner
by: Martyna Sochacka, et al.
Published: (2020-05-01)

FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs
by: Marta Poźniak, et al.
Published: (2021-07-01)

Efficacy and Selectivity of FGF2-Saporin Cytosolically Delivered by PCI in Cells Overexpressing FGFR1
by: Aurora K. Vikan, et al.
Published: (2021-06-01)

Clinical advances and challenges in targeting FGF/FGFR signaling in lung cancer
by: Mei Peng, et al.
Published: (2024-11-01)

FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
by: Martyna Sochacka, et al.
Published: (2022-11-01)

The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells
by: Marta Poźniak, et al.
Published: (2021-05-01)

FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1/β-Klotho pathway
by: Tianli Xu, et al.
Published: (2023-10-01)

FGF8–FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner
by: Venkatram Yellapragada, et al.
Published: (2022-08-01)

ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells
by: Ana Jimenez-Pascual, et al.
Published: (2020-01-01)

Effects of FGF2/FGFR1 Pathway on Expression of A1 Astrocytes After Infrasound Exposure
by: Lin-Hui Zou, et al.
Published: (2019-05-01)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
by: Gerd Jomrich, et al.
Published: (2019-09-01)

A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition
by: Wattamon Srisakuldee, et al.
Published: (2021-10-01)

Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor
by: Krzysztof Ciura, et al.
Published: (2025-05-01)

N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
by: Paulina Gregorczyk, et al.
Published: (2023-07-01)

FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
by: Ranjithkumar Rajendran, et al.
Published: (2021-04-01)

A Comprehensive Analysis of FGF/FGFR Signaling Alteration in NSCLC: Implications in Prognosis and Microenvironment
by: Ziling Huang, et al.
Published: (2025-02-01)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
by: Jinglin Zhang, et al.
Published: (2019-06-01)

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
by: Arianna Giacomini, et al.
Published: (2024-11-01)

GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression
by: Maria Francesca Santolla, et al.
Published: (2019-03-01)

Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
by: Feng Chi, et al.
Published: (2024-03-01)

Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
by: Yanan Liu, et al.
Published: (2020-02-01)

Preferential FGF18/FGFR activity in pseudoglandular versus canalicular stage human lung fibroblasts
by: Randa Belgacemi, et al.
Published: (2023-08-01)

Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma
by: Dimitra Repana, et al.
Published: (2015-10-01)

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
by: Silvana Mouron, et al.
Published: (2021-02-01)

Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells
by: Agata Lampart, et al.
Published: (2022-02-01)

Short‐term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice
by: Jia Nuo Feng, et al.
Published: (2023-03-01)

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients
by: Jianming Xu, et al.
Published: (2023-04-01)

mRNA and protein expression of FGF-1, FGF-2 and their receptors in the porcine umbilical cord during pregnancy
by: Chrusciel M,, et al.
Published: (2010-04-01)

The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions
by: Geetha Parthasarathy, et al.
Published: (2023-01-01)

FGF19–<i>FGFR4</i> Signaling in Hepatocellular Carcinoma
by: Aroosha Raja, et al.
Published: (2019-06-01)

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
by: Alexandra S. Aaldijk, et al.
Published: (2023-05-01)

The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors
by: Wyatt Boothby-Shoemaker, et al.
Published: (2020-10-01)

Pharmacological and Biological Targeting of FGFR1 in Cancer
by: Shuai Fan, et al.
Published: (2024-11-01)

FGF18 augments osseointegration of intra-medullary implants in osteopenic FGFR3-/- mice
by: A Carli, et al.
Published: (2012-07-01)

FGF/FGFR-related lncRNAs based classification predicts prognosis and guides therapy in gastric cancer
by: Qiuxiang Chen, et al.
Published: (2022-08-01)

Emerging Roles of Fibroblast Growth Factor 10 in Cancer
by: Natasha S. Clayton, et al.
Published: (2018-10-01)

Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
by: Jinhao Chen, et al.
Published: (2025-03-01)

The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis
by: Dominika Żukowska, et al.
Published: (2024-05-01)